JP2013500713A5 - - Google Patents

Download PDF

Info

Publication number
JP2013500713A5
JP2013500713A5 JP2012522282A JP2012522282A JP2013500713A5 JP 2013500713 A5 JP2013500713 A5 JP 2013500713A5 JP 2012522282 A JP2012522282 A JP 2012522282A JP 2012522282 A JP2012522282 A JP 2012522282A JP 2013500713 A5 JP2013500713 A5 JP 2013500713A5
Authority
JP
Japan
Prior art keywords
hepatitis
subject
infected
involuntary
polymorphic marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012522282A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013500713A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2010/053139 external-priority patent/WO2011013019A1/en
Publication of JP2013500713A publication Critical patent/JP2013500713A/ja
Publication of JP2013500713A5 publication Critical patent/JP2013500713A5/ja
Pending legal-status Critical Current

Links

JP2012522282A 2009-07-31 2010-07-09 Hcv感染患者においてc型肝炎の転帰を診断又は予測する方法 Pending JP2013500713A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH01201/09 2009-07-31
CH12012009 2009-07-31
US28253810P 2010-02-26 2010-02-26
US61/282,538 2010-02-26
PCT/IB2010/053139 WO2011013019A1 (en) 2009-07-31 2010-07-09 Methods for diagnosing or predicting hepatitis c outcome in hcv infected patients

Publications (2)

Publication Number Publication Date
JP2013500713A JP2013500713A (ja) 2013-01-10
JP2013500713A5 true JP2013500713A5 (enExample) 2013-08-15

Family

ID=42727569

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012522282A Pending JP2013500713A (ja) 2009-07-31 2010-07-09 Hcv感染患者においてc型肝炎の転帰を診断又は予測する方法

Country Status (10)

Country Link
US (1) US20110165124A1 (enExample)
EP (1) EP2459210A1 (enExample)
JP (1) JP2013500713A (enExample)
KR (1) KR20120040725A (enExample)
CN (1) CN102665753A (enExample)
AU (1) AU2010277239A1 (enExample)
BR (1) BR112012001931A2 (enExample)
CA (1) CA2768772A1 (enExample)
MX (1) MX2012001058A (enExample)
WO (1) WO2011013019A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5656159B2 (ja) * 2009-08-24 2015-01-21 独立行政法人理化学研究所 インターフェロン療法の効果予測用マーカー
RU2567806C2 (ru) * 2009-12-22 2015-11-10 ЯНССЕН Ар ЭНД Ди АЙРЛЭНД Усиление прогностической ценности полиморфизма гена il28b в комбинации с количественной оценкой ip-10 в сыворотке при ответе на пегинторферон и рибавирин по сравнению с каждым из этих биомаркеров в отдельности
WO2012107584A1 (en) 2011-02-11 2012-08-16 Universite Pierre Et Marie Curie (Paris 6) Methods for predicting outcome of a hepatitis virus infection
JP2014509628A (ja) * 2011-03-31 2014-04-21 ノバルティス アーゲー C型肝炎ウイルス感染症を治療するためのアリスポリビル
US20140154209A1 (en) * 2011-06-30 2014-06-05 Centre Hospitalier Universitaire Vaudois Polymorphisms associated with non-response to a hepatitis c treatment or susceptibility to non-spontaneous hepatitis c clearance
MX2014001355A (es) 2011-08-03 2014-11-21 Cytheris Inmunoterapia contra el vhc.
JP2013074888A (ja) * 2011-09-15 2013-04-25 Arkray Inc IL28B(rs8099917)とITPA(rs1127354)の変異を検出する方法
US20140271542A1 (en) * 2011-10-05 2014-09-18 The United States Of America As Represented By The Secretary, Department Of Health And Human Service Genetic marker for predicting prognosis in patients infected with hepatitis c virus
GB2515942A (en) 2011-10-21 2015-01-07 Abbvie Inc Combination treatment (e.g. with ABT-072 or ABT-333) of DAAs for use in treating HCV
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
PT107894A (pt) 2011-10-21 2014-10-31 Abbvie Inc Métodos para o tratamento de hcv compreendendo pelo menos dois agentes antivirais de actuação directa, ribavirina, mas não interferão.
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
AU2013240301B2 (en) 2012-03-28 2017-10-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A novel interferon-lambda4 (IFNL4) protein, related nucleic acid molecules, and uses thereof
CN102816838A (zh) * 2012-07-06 2012-12-12 吉林艾迪康医学检验所有限公司 用于检测丙型肝炎患者il28b snp12980275多态性的试剂盒
US11192914B2 (en) 2016-04-28 2021-12-07 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto
CN108220424A (zh) * 2018-02-05 2018-06-29 广州和康医疗技术有限公司 一种检测il28基因位点的方法及试剂盒

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001050A (en) 1989-03-24 1991-03-19 Consejo Superior Investigaciones Cientificas PHφ29 DNA polymerase
US5846717A (en) 1996-01-24 1998-12-08 Third Wave Technologies, Inc. Detection of nucleic acid sequences by invader-directed cleavage
US5888780A (en) 1992-12-07 1999-03-30 Third Wave Technologies, Inc. Rapid detection and identification of nucleic acid variants
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
US6045996A (en) 1993-10-26 2000-04-04 Affymetrix, Inc. Hybridization assays on oligonucleotide arrays
US6068818A (en) 1993-11-01 2000-05-30 Nanogen, Inc. Multicomponent devices for molecular biological analysis and diagnostics
ZA959469B (en) 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
WO1997001603A1 (en) 1995-06-26 1997-01-16 Henkel Corporation Methods of preparing inorganic pigment dispersions
US6001311A (en) 1997-02-05 1999-12-14 Protogene Laboratories, Inc. Apparatus for diverse chemical synthesis using two-dimensional array
WO1999067641A2 (en) 1998-06-24 1999-12-29 Illumina, Inc. Decoding of array sensors with microspheres
GB9817266D0 (en) 1998-08-07 1998-10-07 Imperial College Method
US6429027B1 (en) 1998-12-28 2002-08-06 Illumina, Inc. Composite arrays utilizing microspheres
JP2005204549A (ja) * 2004-01-21 2005-08-04 Hubit Genomix Inc C型肝炎ウイルス感染者の経過に関する遺伝子およびその利用
WO2006003654A2 (en) * 2004-07-01 2006-01-12 Medical Research Fund Of Tel Aviv Sourasky Medical Center Methods and kits for predicting liver fibrosis progression rate in chronic hepatitis c patients
WO2010025380A2 (en) * 2008-08-28 2010-03-04 Vertex Pharmaceuticals Incorporated Analysis of hcv genotypes
WO2010135649A1 (en) * 2009-05-21 2010-11-25 Schering Corporation Genetic markers associated with interferon-alpha response

Similar Documents

Publication Publication Date Title
JP2013500713A5 (enExample)
Cai et al. Comparison of three different HCV genotyping methods: core, NS5B sequence analysis and line probe assay
JP2012518421A5 (enExample)
Moreau et al. Serendipitous identification of natural intergenotypic recombinants of hepatitis C in Ireland
CN104450963B (zh) 一种hbv dna数字pcr定量检测试剂盒及其应用
Besse et al. Genotyping and resistance profile of hepatitis C (HCV) genotypes 1–6 by sequencing the NS3 protease region using a single optimized sensitive method
Zhong et al. A novel method for detection of HBVcccDNA in hepatocytes using rolling circle amplification combined with in situ PCR
WO2007084567A3 (en) Detection and discrimination of hepatitis c virus, human immunodeficiency virus type-1 and hepatitis b virus
Nishimura et al. Detection of noroviruses in fecal specimens by direct RT-PCR without RNA purification
JP2011041526A5 (enExample)
Ergünay et al. Utility of a commercial quantitative hepatitis C virus core antigen assay in a diagnostic laboratory setting
Niesters et al. Detection of hepatitis B virus genotypes and mutants: current status
Amini-Bavil-Olyaee et al. Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine
Cai et al. Development of a novel genotype-specific loop-mediated isothermal amplification technique for Hepatitis B virus genotypes B and C genotyping and quantification
Chantratita et al. 6 HCV genotyping 9G test and its comparison with VERSANT HCV genotype 2.0 assay (LiPA) for the hepatitis C virus genotyping
JP2014083052A5 (enExample)
Vincenti et al. A sensitive direct sequencing assay based on nested PCR for the detection of HBV polymerase and surface glycoprotein mutations
Saha et al. A novel nested reverse-transcriptase polymerase chain reaction method for rapid hepatitis C virus detection and genotyping
Pabbaraju et al. Adamantane resistance in seasonal human influenza A viruses from Calgary, Alberta (January 2007 to August 2008)
Kao et al. Clinical evaluation of IntelliPlexTM HCV genotyping kit for hepatitis C virus genotyping
WO2009091148A3 (en) Primer, probe, dna chip containing the same and method for detecting human papillomavirus and detection kit thereof
Kareem et al. Hepatitis C Virus Genotyping In Sulaimani Governorate
WO2013093992A1 (ja) B型肝炎ウイルス群を検出し、遺伝子多様性を評価するためのオリゴヌクレオチドのセット、並びにそれを用いた方法
WO2007059348A3 (en) Compositions and methods for detecting an hcv-1 subtype
Kaklikkaya et al. Hepatitis B virus genotypes and subgenotypes in the Eastern Black Sea region of Turkey